Problems of Combination Drug Therapy in Children

Epilepsia

Volumn 29, Issue , 1988, Pages S20-S24

  Bourgeois, B F D ^a  

^a SWISS EPILEPSY CENTER   (Switzerland)

Author keywords

Key Words: Epilepsy Anticonvulsants Drug interactions Drug induced abnormalities Bio pharmacokinetics

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

BENIGN CHILDHOOD EPILEPSY; CHILD; DRUG COMBINATION; FEMALE; HUMAN; MALE; NEUROTOXICITY; PRIORITY JOURNAL;

ANTICONVULSANTS; CHILD; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; HUMAN;

EID: 0024215039     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1988.tb05806.x     Document Type: Article

References (39)

1. Reduction of polypharmacy in epileptic patients
2. Reduction of polypharmacy for epilepsy in an institution for the retarded
3. Intelligence in epilepsy: A prospective study in children
4. Carbamazepine‐10,11‐epoxide in mice
5. Carbamazepine‐10,11‐diol steady‐state serum levels and renal excretion during carbamazepine therapy in adults and children
6. Anti‐epileptic drug combinations and experimental background: The case of phenobarbital and phenytoin
7. Combined administration of carbamazepine and phenobarbital: effect on anticonvulsant activity and neurotoxicity
8. Interactions of valproic acid with phenytoin
9. Valproic acid pharmacokinetics in children. II. Discontinuation of concomitant anti‐epileptic drug therapy
10. Effect of reduction of anticonvulsants on wellbeing
11. Chronic valproic acid therapy and incidence of increases in venous plasma ammonia
12. Clinical and pharmacokinetic observations on sodium valproate–a 5‐year study in 100 children with epilepsy
13. Treatment of generalized epilepsies of childhood and adolescence with sodium valproate (Epilim)
14. Mechanism of valproate‐phenobarbital interaction in epileptic patients
15. Anticonvulsant activity of phenobarbital and phenytoin in combination
16. A controlled study of progabide in partial seizures: methodology and results
17. High‐dose monotherapy in treatment of intractable seizures
18. Carbamazepine/valproic acid interaction in man and rhesus monkey
19. Stuporous episodes during treatment with sodium valproate: report of seven cases
20. Valproate. Interactions with other drugs
21. Valproic acid and ethosuximide interaction
22. Phenytoin and carbamazepine alone and in combination: anticonvulsant and neurotoxic effects
23. Valproic acid‐ethosuximide interaction: a pharmacokinetic study
24. Sodium valproate and valpromide: Differential interaction with carbamazepine in epileptic patients
25. General principles: Clinical efficacy and use of antiepileptic drugs
26. Sodium valproate: pharmacokinetics and effectiveness in treating intractable seizures
27. Low serum valproic acid concentrations in epileptic patients on combination therapy
28. Single drug or combination therapy for epilepsy
29. Dissociation between free and bound phenytoin levels in presence of valproate sodium
30. Valproate‐ethosuximide combination therapy for refractory absence seizures
31. Stupor following administration of valproic acid to patients receiving other anti‐epileptic drugs
32. Reduction of steady‐state valproate levels by other antiepileptic drugs
33. Reduction of two‐drug therapy in intractable epilepsy
34. Correlation between plasma carbamazepine‐10,‐II‐epoxide concentration and drug side effect in children with epilepsy
35. Removal of sedative‐hypnotic antiepileptic drugs from the regimen of patients with intractable epilepsy
36. Anticonvulsant drugs, cognitive function, and behaviour
37. Rôle de ľhyperammon‐iémie dans les états stuporeux induits par le valproate de sodium
38. Effect of associated antiepileptic treatment on valproate‐induced hyperammonaemia